Epstein-barr virus as a trigger of autoimmune liver diseases

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Rigopoulou, Eirini I ^a   Smyk, Daniel S ^b   Matthews, Claire E ^b   Billinis, Charalambos ^a   Burroughs, Andrew K ^c   Lenzi, Marco ^d   Bogdanos, Dimitrios P ^a,b,e  

^a UNIVERSITY OF THESSALY   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 4;

EID: 84869433874     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/987471     Document Type: Review

References (155)

1. Bach J. F., Infections and autoimmune diseases. Journal of Autoimmunity 2005 25, supplement 74 80
2. Barzilai O., Ram M., Shoenfeld Y., Viral infection can induce the production of autoantibodies. Current Opinion in Rheumatology 2007 19 6 636 643 2-s2.0-34948879087 10.1097/BOR.0b013e3282f0ad25 (Pubitemid 47530886)
3. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J. M., Shoenfeld Y., Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? a preliminary report. Annals of the New York Academy of Sciences 2007 1108 567 577 2-s2.0-34948875236 10.1196/annals.1422.059 (Pubitemid 47528770)
4. Ercolini A. M., Miller S. D., The role of infections in autoimmune disease. Clinical and Experimental Immunology 2009 155 1 1 15 2-s2.0-57449091100 10.1111/j.1365-2249.2008.03834.x
5. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y., Infections and autoimmunity-friends or foes? Trends in Immunology 2009 30 8 409 414 2-s2.0-68149091433 10.1016/j.it.2009.05.005
6. Pordeus V., Szyper-Kravitz M., Levy R. A., Vaz N. M., Shoenfeld Y., Infections and autoimmunity: a panorama. Clinical Reviews in Allergy and Immunology 2008 34 3 283 299 2-s2.0-49349106442 10.1007/s12016-007-8048-8
7. Posnett D. N., Herpesviruses and autoimmunity. Current Opinion in Investigational Drugs 2008 9 5 505 514 2-s2.0-43549118633 (Pubitemid 351677905)
8. Toussirot É., Roudier J., Epstein-Barr virus in autoimmune diseases. Best Practice and Research: Clinical Rheumatology 2008 22 5 883 896 2-s2.0-57049087977 10.1016/j.berh.2008.09.007
9. James J. A., Kaufman K. M., Farris A. D., Taylor-Albert E., Lehman T. J. A., Harley J. B., An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. Journal of Clinical Investigation 1997 100 12 3019 3026 2-s2.0-0031465706 (Pubitemid 28022839)
10. Evans A. S., E. B. virus antibody in systemic lupus erythematosus. Lancet 1971 1 7707 1023 1024 2-s2.0-0015225548
11. Evans A. S., Rothfield N. F., Niederman J. C., Raised antibody titres to E. B. virus in systemic lupus erythematosus. Lancet 1971 1 7691 167 168 2-s2.0-0015236918
12. Poole B. D., Scofield R. H., Harley J. B., James J. A., Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006 39 1 63 70 2-s2.0-33745115404 10.1080/08916930500484849 (Pubitemid 43878521)
13. Harley B. J., Harley I. T. W., Guthridge J. M., James J. A., The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 2006 15 11 768 777 2-s2.0-34250662605 10.1177/0961203306070009
14. Costenbader K. H., Karlson E. W., Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Research and Therapy 2006 8 1 204 2-s2.0-33144472845 10.1186/ar1893 (Pubitemid 43264492)
15. Levin L. I., Munger K. L., Rubertone M. V., Peck C. A., Lennette E. T., Spiegelman D., Ascherio A., Multiple sclerosis and Epstein-Barr virus. Journal of the American Medical Association 2003 289 12 1533 1536 2-s2.0-0037467342 10.1001/jama.289.12.1533 (Pubitemid 37430292)
16. Haahr S., Höllsberg P., Multiple sclerosis is linked to Epstein-Barr virus infection. Reviews in Medical Virology 2006 16 5 297 310 2-s2.0-33749330705 10.1002/rmv.503 (Pubitemid 44497311)
17. Padalko E. Y., Bossuyt X., Anti-dsdna antibodies associated with acute ebv infection in sjögren's syndrome. Annals of the Rheumatic Diseases 2001 60 10 992 2-s2.0-0034834090 10.1136/ard.60.10.992 (Pubitemid 32885686)
18. Trimeche M., Ziadi S., Amara K., Khelifa M., Bahri F., Mestiri S., Braham H., Hachana M., Sriha B., Mokni M., Korbi S., Prevalence ofEpstein-Barr virus insjögren's syndrome intunisia. Revue De Medecine Interne 2006 27 7 519 523 2-s2.0-33745699322 10.1016/j.revmed.2006.03.034
19. Vrbikova J., Janatkova I., Zamrazil V., Tomiska R., Fucikova T., Epstein-Barr virus serology in patients with autoimmune thyroiditis. Experimental and Clinical Endocrinology and Diabetes 1996 104 1 89 92 2-s2.0-0030067215 (Pubitemid 26035646)
20. Vento S., Guella L., Mirandola F., Cainelli F., Di Perri G., Solbiati M., Ferraro T., Concia E., Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995 346 8975 608 609 2-s2.0-0029129699
21. Pollard K. M., Gender differences in autoimmunity associated with exposure to environmental factors. Journal of Autoimmunity 2012 38 2-3 J177 J186
22. Smyk D., Rigopoulou E. I., Baum H., Burroughs A. K., Vergani D., Bogdanos D. P., Autoimmunity and environment: am i at risk? Clinical Reviews in Allergy and Immunology 2011 1 14 2-s2.0-79951583545 10.1007/s12016-011-8259-x
23. Jacobson D. L., Gange S. J., Rose N. R., Graham N. M. H., Epidemiology and estimated population burden of selected autoimmune diseases in the united states. Clinical Immunology and Immunopathology 1997 84 3 223 243 2-s2.0-0031240055 10.1006/clin.1997.4412 (Pubitemid 27398022)
24. Leslie R. D. G., Hawa M., Twin studies in auto-immune disease. Acta Geneticae Medicae Et Gemellologiae 1994 43 1-2 71 81 2-s2.0-0028122808 (Pubitemid 24305877)
25. Selmi C., Mayo M. J., Bach N., Ishibashi H., Invernizzi P., Gish R. G., Gordon S. C., Wright H. I., Zweiban B., Podda M., Gershwin M. E., Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004 127 2 485 492 2-s2.0-4143103585 10.1053/j.gastro.2004.05.005 (Pubitemid 39091897)
26. Cooper G. S., Wither J., Bernatsky S., Claudio J. O., Clarke A., Rioux J. D., Fortin P. R., Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology 2010 49 11 2172 2180 2-s2.0-78649387840 10.1093/rheumatology/keq214 keq214
27. Jarvinen P., Aho K., Twin studies in rheumatic disease. Seminars in Arthritis and Rheumatism 1994 24 1 19 28 2-s2.0-0028031370 10.1016/0049-0172(94) 90096-5 (Pubitemid 24258758)
28. Bogdanos D. P., Smyk D. S., Rigopoulou E. I., Heneghan M. A, Selmi C., Gershwin M. E., Twin studies in autoimmune disease: genetics, gender and environment. Journal of Autoimmunity 2012 38 2-3 J156 J169
29. Christen U., Hintermann E., Holdener M., von Herrath M. G., Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? Journal of Autoimmunity 2010 34 1 38 44 2-s2.0-75149177988 10.1016/j.jaut.2009.08.001
30. Bogdanos D. P., Lenzi M., Okamoto M., Rigopoulou E. I., Muratori P., Ma Y., Muratori L., Tsantoulas D., Mieli-Vergani G., Bianchi F. B., Vergani D., Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus-infected patients is associated with the possession of HLA B51. International Journal of Immunopathology and Pharmacology 2004 17 1 83 92 2-s2.0-5444251837 (Pubitemid 39572192)
31. Bogdanos D. P., McFarlane I. G., Cytochrome P450 2A6 meets P450 2D6: an enigma of viral infections and autoimmunity. Journal of Hepatology 2003 39 5 860 863 2-s2.0-0242606322 10.1016/S0168-8278(03)00417-3 (Pubitemid 37372199)
32. Lleo A., Selmi C., Invernizzi P., Podda M., Gershwin M. E., The consequences of apoptosis in autoimmunity. Journal of Autoimmunity 2008 31 3 257 262 2-s2.0-56349147804 10.1016/j.jaut.2008.04.009
33. Alunno A., Bartoloni E., Nocentini G., Bistoni O., Ronchetti S., Petrillo M. G., Riccardi C., Gerli R., Role of regulatory t cells in rheumatoid arthritis: facts and hypothesis. Autoimmunity Highlights 2010 1 1 45 51 2-s2.0-78249243246 10.1007/s13317-010-0008-2
34. Lettre G., Rioux J. D., Autoimmune diseases: insights from genome-wide association studies. Human Molecular Genetics 2008 17 2 R116 121 2-s2.0-58149333555 10.1093/hmg/ddn246
35. Gourley M., Miller F. W., Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nature Clinical Practice Rheumatology 2007 3 3 172 180 2-s2.0-33947260259 10.1038/ncprheum0435 (Pubitemid 46416266)
36. Pender M. P., Infection of autoreactive b lymphocytes with ebv, causing chronic autoimmune diseases. Trends in Immunology 2003 24 11 584 588 2-s2.0-0242270822 10.1016/j.it.2003.09.005 (Pubitemid 37338526)
37. Thorley-Lawson D. A., Epstein-Barr virus: exploiting the immune system. Nature Reviews Immunology 2001 1 1 75 82 2-s2.0-0035496101 (Pubitemid 33741978)
38. Garzelli C., Taub F. E., Scharff J. E., Prabhakar B. S., Ginsberg-Fellner F., Notkins A. L., Epstein-Barr virus-transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. Journal of Virology 1984 52 2 722 725 (Pubitemid 15200232)
39. Manns M. P., Czaja A. J., Gorham J. D., Krawitt E. L., Mieli-Vergani G., Vergani D., Vierling J. M., Diagnosis and management of autoimmune hepatitis. Hepatology 2010 51 6 2193 2213 2-s2.0-77952711598 10.1002/hep.23584
40. Vergani D., Longhi M. S., Bogdanos D. P., Ma Y., Mieli-Vergani G., Autoimmune hepatitis. Seminars in Immunopathology 2009 31 3 421 435 2-s2.0-70349579057 10.1007/s00281-009-0170-7
41. Mieli-Vergani G., Vergani D., Autoimmune hepatitis in children. Clinics in Liver Disease 2002 6 3 335 346 2-s2.0-0036695054
42. Mieli-Vergani G., Vergani D., Autoimmune liver disease in children. Annals of the Academy of Medicine Singapore 2003 32 2 239 243 2-s2.0-0038344157 (Pubitemid 36827743)
43. Mieli-Vergani G., Vergani D., Autoimmune paediatric liver disease. World Journal of Gastroenterology 2008 14 21 3360 3367 2-s2.0-54349109150 10.3748/wjg.14.3360
44. Mieli-Vergani G., Vergani D., Autoimmune hepatitis in children: what is different from adult aih? Seminars in Liver Disease 2009 29 3 297 306 2-s2.0-68849121460 10.1055/s-0029-1233529
45. Longhi M. S., Ma Y., Mieli-Vergani G., Vergani D., Aetiopathogenesis of autoimmune hepatitis. Journal of Autoimmunity 2010 34 1 7 14 2-s2.0-75149198542 10.1016/j.jaut.2009.08.010
46. Vergani D., Choudhuri K., Bogdanos D. P., Mieli-Vergani G., Pathogenesis of autoimmune hepatitis. Clinics in Liver Disease 2002 6 3 439 449 2-s2.0-0036694470
47. Vergani D., Mieli-Vergani G., Aetiopathogenesis of autoimmune hepatitis. World Journal of Gastroenterology 2008 14 21 3306 3312 2-s2.0-54349127866 10.3748/wjg.14.3306
48. Bogdanos D. P., Invernizzi P., Mackay I. R., Vergani D., Autoimmune liver serology: current diagnostic and clinical challenges. World Journal of Gastroenterology 2008 14 21 3374 3387 2-s2.0-54349118451 10.3748/wjg.14.3374
49. Bogdanos D. P., Mieli-Vergani G., Vergani D., Autoantibodies and their antigens in autoimmune hepatitis. Seminars in Liver Disease 2009 29 3 241 253 2-s2.0-68849130635 10.1055/s-0029-1233533
50. Vergani D., Mieli-Vergani G., Pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2011 12 4 607 613 2-s2.0-79951604117 10.1517/14656566.2011.524206
51. Manns M. P., Vergani D., Autoimmune hepatitis. Seminars in Liver Disease 2009 29 3 239 240 2-s2.0-68849089997 10.1055/s-0029-1233528
52. Longhi M. S., Hussain M. J., Mitry R. R., Arora S. K., Mieli-Vergani G., Vergani D., Ma Y., Functional study of CD4+CD25+ regulatory t cells in health and autoimmune hepatitis. Journal of Immunology 2006 176 7 4484 4491 2-s2.0-33646052605 (Pubitemid 44264429)
53. Longhi M. S., Ma Y., Bogdanos D. P., Cheeseman P., Mieli-Vergani G., Vergani D., Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. Journal of Hepatology 2004 41 1 31 37 2-s2.0-3442885909 10.1016/j.jhep.2004.03.008 (Pubitemid 39005149)
54. Longhi M. S., Ma Y., Mitry R. R., Bogdanos D. P., Heneghan M., Cheeseman P., Mieli-Vergani G., Vergani D., Effect of CD4(+)CD25(+) regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. Journal of Autoimmunity 2005 25 1 63 71 2-s2.0-22444436491 10.1016/j.jaut.2005.05.001 (Pubitemid 41008667)
55. Longhi M. S., Mitry R. R., Samyn M., Scalori A., Hussain M. J., Quaglia A., Mieli-Vergani G., Ma Y., Vergani D., Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology 2009 50 1 130 142 2-s2.0-67651156354 10.1002/hep.22914
56. Aceti A., Mura M. S., Babudieri S., Bacciu S. A., A young woman with hepatitis after a sore throat. Lancet 1995 346 8990 1603 2-s2.0-13344275180 10.1016/S0140-6736(95)91932-5 (Pubitemid 26001844)
57. Kojima K., Nagayama R., Hirama S., Maeda T., Takikawa H., Miyake K., Yamanaka M., Shiga J., Epstein-Barr virus infection resembling autoimmune hepatitis with lactate dehydrogenase and alkaline phosphatase anomaly. Journal of Gastroenterology 1999 34 6 706 712 2-s2.0-0032787538 10.1007/s005350050324
58. Nobili V., Comparcola D., Sartorelli M. R., Devito R., Marcellini M., Autoimmune hepatitis type 1 after Epstein-Barr virus infection. Pediatric Infectious Disease Journal 2003 22 4 387 2-s2.0-0242416536 (Pubitemid 36461053)
59. Chiba T., Goto S., Yokosuka O., Imazeki F., Tanaka M., Fukai K., Takahashi Y., Tsujimura H., Saisho H., Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. European Journal of Gastroenterology and Hepatology 2004 16 2 225 228 2-s2.0-2642530302 10.1097/00042737-200402000- 00017 (Pubitemid 39049662)
60. Nakajima S., Umebayashi H., Kurosawa R., Imagawa T., Katakura S., Mori M., Aihara Y., Yokota S., Sogo T., Inui A., Fujisawa T., Hanzawa N., A case of autoimmune hepatitis needed to be differentiated from ebv hepatitis, in that the histology of liver biopsy specimen was useful for diagnosis. Nihon Rinsho Men'eki Gakkai Kaishi 2005 28 3 154 158 2-s2.0-23444438533
61. Cabibi D, Autoimmune hepatitis following Epstein-Barr virus infection. BMJ Case Reports 2008 2008 bcr0620080071
62. Kaplan M. M., Gershwin M. E., Primary biliary cirrhosis. New England Journal of Medicine 2005 353 12 1261 1273 2-s2.0-25144474552 10.1056/NEJMra043898 (Pubitemid 41345948)
63. Hohenester S., Oude-Elferink R. P. J., Beuers U., Primary biliary cirrhosis. Seminars in Immunopathology 2009 31 3 283 307 2-s2.0-70349565497 10.1007/s00281-009-0164-5
64. Neuberger J., Primary biliary cirrhosis. Lancet 1997 350 9081 875 879 2-s2.0-0030826869 10.1016/S0140-6736(97)05419-6 (Pubitemid 27404357)
65. James O. E. W., Bhopal R., Howel D., Gray J., Burt A. D., Metcalf J. V., Primary biliary cirrhosis once rare, now common in the united kingdom? Hepatology 1999 30 2 390 394 2-s2.0-0032765659 10.1002/hep.510300213 (Pubitemid 29357502)
66. Kim W. R., Lindor K. D., Locke G. R., Therneau T. M., Homburger H. A., Batts K. P., Yawn B. P., Petz J. L., Melton J., Dickson E. R., Epidemiology and natural history of primary biliary cirrhosis in a u.s. community. Gastroenterology 2000 119 6 1631 1636 2-s2.0-0034465973 (Pubitemid 32198688)
67. Sood S., Gow P. J., Christie J. M., Angus P. W., Epidemiology of primary biliary cirrhosis in victoria, australia: high prevalence in migrant populations. Gastroenterology 2004 127 2 470 475 2-s2.0-4143070279 10.1053/j.gastro.2004.04.064 (Pubitemid 39091895)
68. Rautiainen H., Salomaa V., Niemela S., Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scandinavian Journal of Gastroenterology 2007 42 11 1347 1353 (Pubitemid 47537072)
69. Bogdanos D. P., Baum H., Vergani D., Antimitochondrial and other autoantibodies. Clinics in Liver Disease 2003 7 4 759 777 2-s2.0-0141960202 10.1016/S1089-3261(03)00104-1 (Pubitemid 37229503)
70. Pavlidis P., Mytilinaiou M. G., Roggenbuck D., Conrad K., Forbes A., Bogdanos D. P., Pancreatic GP2-specific autoantibodies are markers of crohn's disease. Gut 2011 60, supplement A212 A213
71. Dähnrich C., Pares A., Caballeria L., Rosemann A., Schlumberger W., Probst C., Mytilinaiou M., Bogdanos D., Vergani D., Stöcker W., Komorowski L., New elisa for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clinical Chemistry 2009 55 5 978 985 2-s2.0-65949104832 10.1373/clinchem.2008.118299
72. Liu H., Norman G. L., Shums Z., Worman H. J., Krawitt E. L., Bizzaro N., Vergani D., Bogdanos D. P., Dalekos G. N., Milkiewicz P., Czaja A. J., Heathcote E. J., Hirschfield G. M., Tan E. M., Miyachi K., Bignotto M., Battezzati P. M., Lleo A., Leung P. S., Podda M., Gershwin M. E., Invernizzi P., Pbc screen: an igg/iga dual isotype elisa detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. Journal of Autoimmunity 2010 35 4 436 442 2-s2.0-77958150189 10.1016/j.jaut.2010.09.005
73. Hannam S., Bogdanos D. P., Davies E. T., Hussain M. J., Portmann B. C., Mieli-Vergani G., Vergani D., Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies. Autoimmunity 2002 35 8 545 550 2-s2.0-20244383696 10.1080/0891693021000054057 (Pubitemid 36321896)
74. Rigopoulou E. I., Davies E. T., Bogdanos D. P., Liaskos C., Mytilinaiou M., Koukoulis G. K., Dalekos G. N., Vergani D., Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis. Liver International 2007 27 9 1226 1231 2-s2.0-35148835681 10.1111/j.1478-3231.2007.01586.x (Pubitemid 47543151)
75. Vergani D., Bogdanos D. P., Positive markers in AMA-negative PBC. American Journal of Gastroenterology 2003 98 2 241 243 2-s2.0-0037282886 10.1111/j.1572-0241.2003.07270.x (Pubitemid 36232366)
76. Wen L., Ma Y., Bogdanos D. P., Susan Wong F., Demaine A., Mieli-Vergani G., Vergani D., Pédiatrie autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Current Molecular Medicine 2001 1 3 379 389 2-s2.0-0035411635 (Pubitemid 33772964)
77. Invernizzi P., Lleo A., Podda M., Interpreting serological tests in diagnosing autoimmune liver diseases. Seminars in Liver Disease 2007 27 2 161 172 2-s2.0-34249886050 10.1055/s-2007-979469 (Pubitemid 46871662)
78. Rigopoulou E. I., Bogdanos D. P., Liaskos C., Koutsoumpas A., Baum H., Vergani D., Dalekos G. N., Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis. Clinica Chimica Acta 2007 380 1-2 118 121 2-s2.0-34047168641 10.1016/j.cca.2007.01.023 (Pubitemid 46509627)
79. Metcalf J. V., Mitchison H. C., Palmer J. M., Jones D. E., Bassendine M. F., James O. F. W., Natural history of early primary biliary cirrhosis. Lancet 1996 348 9039 1399 1402 2-s2.0-0012453837 10.1016/S0140-6736(96)04410-8 (Pubitemid 26395233)
80. Courvalin J. C., Worman H. J., Nuclear envelope protein autoantibodies in primary biliary cirrhosis. Seminars in Liver Disease 1997 17 1 79 90 2-s2.0-0030903041 (Pubitemid 27157374)
81. Mytilinaiou M. G., Bogdanos D. P., Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis. Digestive and Liver Disease 2009 41 12 916 2-s2.0-70350586450 10.1016/j.dld.2009.05.005
82. Invernizzi P., Selmi C., Ranftler C., Podda M., Wesierska-Gadek J., Antinuclear antibodies in primary biliary cirrhosis. Seminars in Liver Disease 2005 25 3 298 310 2-s2.0-24344476669 10.1055/s-2005-916321 (Pubitemid 41254577)
83. Bogdanos D. P., Liaskos C., Pares A., Norman G., Rigopoulou E. I., Caballeria L., Dalekos G. N., Rodes J., Vergani D., Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis. Hepatology 2007 45 6 1583 2-s2.0-34250325098 10.1002/hep.21678 (Pubitemid 46918344)
84. Bogdanos D. P., Liaskos C., Rigopoulou E. I., Dalekos G. N., Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clinica Chimica Acta 2006 373 1-2 183 184 (Pubitemid 44308539)
85. Bogdanos D. P., Pares A., Rodes J., Vergani D., Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. The American Journal of Gastroenterology 2004 99 4 763 764
86. Invernizzi P., Podda M., Battezzati P. M., Crosignani A., Zuin M., Hitchman E., Maggioni M., Meroni P. L., Penner E., Wesierska-Gadek J., Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. Journal of Hepatology 2001 34 3 366 372 2-s2.0-0035073026 10.1016/S0168-8278(00)00040-4 (Pubitemid 32240814)
87. Miyachi K., Hankins R. W., Matsushima H., Kikuchi F., Inomata T., Horigome T., Shibata M., Onozuka Y., Ueno Y., Hashimoto E., Hayashi N., Shibuya A., Amaki S., Miyakawa H., Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. Journal of Autoimmunity 2003 20 3 247 254 2-s2.0-12444277805 10.1016/S0896-8411(03)00033-7 (Pubitemid 36561490)
88. Nakamura M., Kondo H., Mori T., Komori A., Matsuyama M., Ito M., Takii Y., Koyabu M., Yokoyama T., Migita K., Daikoku M., Abiru S., Yatsuhashi H., Takezaki E., Masaki N., Sugi K., Honda K., Adachi H., Nishi H., Watanabe Y., Nakamura Y., Shimada M., Komatsu T., Saito A., Saoshiro T., Harada H., Sodeyama T., Hayashi S., Masumoto A., Sando T., Yamamoto T., Sakai H., Kobayashi M., Muro T., Koga M., Shums Z., Norman G. L., Ishibashi H., Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007 45 1 118 127 2-s2.0-33846449067 10.1002/hep.21472 (Pubitemid 46144371)
89. Rigopoulou E. I., Davies E. T., Pares A., Zachou K., Liaskos C., Bogdanos D. P., Rodes J., Dalekos G. N., Vergani D., Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005 54 4 528 532 2-s2.0-15444366750 10.1136/gut.2003.036558 (Pubitemid 40395506)
90. Dubel L., Tanaka A., Leung P. S. C., Van De Water J., Coppel R., Roche T., Johanet C., Motokawa Y., Ansari A., Gershwin M. E., Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology 1999 29 4 1013 1018 2-s2.0-0032953747 (Pubitemid 29168730)
91. Leung P. S. C., Coppel R. L., Ansari A., Munoz S., Gershwin M. E., Antimitochondrial antibodies in primary biliary cirrhosis. Seminars in Liver Disease 1997 17 1 61 69 2-s2.0-0030914714 (Pubitemid 27157372)
92. Palmer J. M., Jones D. E. J., Quinn J., McHugh A., Yeaman S. J., Characterization of the autoantibody responses to recombinant e3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis. Hepatology 1999 30 1 21 26 2-s2.0-0033000884 10.1002/hep.510300106 (Pubitemid 29300564)
93. Van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., Coppel R., Gershwin M. E., Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. Journal of Immunology 1988 141 7 2321 2324 2-s2.0-0023813733
94. Itoh S., Ichida T., Yoshida T., Hayakawa A., Uchida M., Tashiro-Itoh T., Matsuda Y., Ishihara K., Asakura H., Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 1998 13 3 257 265 2-s2.0-0031946553 (Pubitemid 28183956)
95. Lassoued K., Guilly M. N., Andre C., Paintrand M., Dhumeaux D., Danon F., Brouet J. C., Courvalin J. C., Autoantibodies to 200 kd polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clinical and Experimental Immunology 1988 74 2 283 288 2-s2.0-0023790694
96. Muratori P., Muratori L., Ferrari R., Cassani F., Bianchi G., Lenzi M., Rodrigo L., Linares A., Fuentes D., Bianchi F. B., Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. American Journal of Gastroenterology 2003 98 2 431 437 2-s2.0-0037283230 10.1111/j.1572-0241. 2003.07257.x (Pubitemid 36232395)
97. Wesierska-Gadek J., Penner E., Battezzati P. M., Selmi C., Zuin M., Hitchman E., Worman H. J., Gershwin M. E., Podda M., Invernizzi P., Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006 43 5 1135 1144 2-s2.0-33646571925 10.1002/hep.21172 (Pubitemid 43724638)
98. Yang W. H., Yu J. H., Nakajima A., Neuberg D., Lindor K., Bloch D. B., Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clinical Gastroenterology and Hepatology 2004 2 12 1116 1122 2-s2.0-11144330639 10.1016/S1542-3565(04)00465-3 (Pubitemid 40037643)
99. Gershwin M. E., Selmi C., Worman H. J., Gold E. B., Watnik M., Utts J., Lindor K. D., Kaplan M. M., Vierling J. M., Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology 2005 42 5 1194 1202 2-s2.0-30944437302 10.1002/hep.20907 (Pubitemid 43112687)
100. Hudson M., Rojas-Villarraga A., Coral-Alvarado P., López- Guzmán S., Mantilla R. D., Chalem P., Baron M., Anaya J. M., Polyautoimmunity and familial autoimmunity in systemic sclerosis. Journal of Autoimmunity 2008 31 2 156 159 2-s2.0-50549096136 10.1016/j.jaut.2008.05.002
101. European Association for the Study of the Liver, Easl clinical practice guidelines: management of cholestatic liver diseases. Journal of Hepatology 2009 51 2 237 267 2-s2.0-67649205149 10.1016/j.jhep.2009.04.009
102. Poupon R., Primary biliary cirrhosis: a 2010 update. Journal of Hepatology 2010 52 5 745 758 2-s2.0-77951634696 10.1016/j.jhep.2009.11.027
103. Corpechot C., Carrat F., Poupon R., Poupon R., Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002 122 3 652 658 2-s2.0-0036182838 (Pubitemid 34173817)
104. Selmi C., Meda F., Kasangian A., Invernizzi P., Tian Z., Lian Z., Podda M., Gershwin M. E., Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cellular and Molecular Immunology 2010 7 1 1 10 2-s2.0-75949084877 10.1038/cmi.2009.104
105. Gershwin M. E., Mackay I. R., The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008 47 2 737 745 2-s2.0-39549115685 10.1002/hep.22042 (Pubitemid 351280742)
106. Bogdanos D. P., Baum H., Vergani D., Burroughs A. K., The role of E. coli infection in the pathogenesis of primary biliary cirrhosis. Disease Markers 2010 29 6 301 311 2-s2.0-79951629112 10.3233/DMA-2010-0745
107. Bogdanos D. P., Vergani D., Origin of cross-reactive autoimmunity in primary biliary cirrhosis. Liver International 2006 26 6 633 635 2-s2.0-33745610428 10.1111/j.1478-3231.2006.01291.x (Pubitemid 43983878)
108. Bogdanos D. P., Vergani D., Bacteria and primary biliary cirrhosis. Clinical Reviews in Allergy and Immunology 2009 36 1 30 39 2-s2.0-61949474897 10.1007/s12016-008-8087-9
109. Gershwin M. E., Mackay I. R., Primary biliary cirrhosis: paradigm or paradox for autoimmunity. Gastroenterology 1991 100 3 822 833 2-s2.0-0026034491
110. Jones D. E. J., Enesis of primary biliary cirrhosis. Gut 2007 56 11 1615 1624 2-s2.0-35648958686 10.1136/gut.2007.122150 (Pubitemid 350033203)
111. Mackay I. R., Whittingham S., Fida S., Myers M., Ikuno N., Gershwin M. E., Rowley M. J., The peculiar autoimmunity of primary biliary cirrhosis. Immunological Reviews 2000 174 226 237 2-s2.0-0034085812 10.1034/j.1600-065X. 2000.174001226.x (Pubitemid 30201391)
112. Shimoda S., Nakamura M., Ishibashi H., Hayashida K., Niho Y., Hla drb4 0101-restricted immunodominant t cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. Journal of Experimental Medicine 1995 181 5 1835 1845 2-s2.0-0028905099
113. Shimoda S., Nakamura M., Shigematsu H., Tanimoto H., Gushima T., Gershwin M. E., Ishibashi H., Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology 2000 31 6 1212 1216 2-s2.0-0034076796 (Pubitemid 30351280)
114. Shimoda S., Van De Water J., Ansari A., Nakamura M., Ishibashi H., Coppel R. L., Lake J., Keeffe E. B., Roche T. E., Gershwin M. E., Identification and precursor frequency analysis of a common t cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. Journal of Clinical Investigation 1998 102 10 1831 1840 2-s2.0-7844229417 (Pubitemid 28533830)
115. Smyk D., Cholongitas E., Kriese S., Rigopoulou E. I., Bogdanos D. P., Primary biliary cirrhosis: family stories. Autoimmune Diseases 2011 2011 11 10.4061/2011/189585 189585
116. Smyk D. S., Bogdanos D. P., Kriese S., Billinis C., Burroughs A. K., Rigopoulou E. I., Urinary tract infection as a risk factor for autoimmune liver disease: from bench to bedside. Clinics and Research in Hepatology and Gastroenterology 2012 36 2 110 121
117. Smyk D. S., Rigopoulou E. I., Lleo A., Immunopathogenesis of Primary biliary cirrhosis: an old wives' tale. Immunity & Ageing 2011 8 1 12
118. Agmon-Levin N., Katz B. S., Shoenfeld Y., Infection and primary biliary cirrhosis. The Israel Medical Association Journal 2009 11 2 112 115 2-s2.0-66149085667
119. Morshed S. A., Nishioka M., Saito I., Komiyama K., Moro I., Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients. Gastroenterologia Japonica 1992 27 6 751 758 2-s2.0-0027070606 (Pubitemid 23066541)
120. Lidar M., Langevitz P., Barzilai O., Ram M., Porat-Katz B. S., Bizzaro N., Tonutti E., Maieron R., Chowers Y., Bar-Meir S., Shoenfeld Y., Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Annals of the New York Academy of Sciences 2009 1173 640 648 2-s2.0-69949167180 10.1111/j.1749-6632.2009.04673.x
121. Yanai H., Shimizu N., Nagasaki S., Mitani N., Okita K., Epstein-Barr virus infection of the colon with inflammatory bowel disease. American Journal of Gastroenterology 1999 94 6 1582 1586 2-s2.0-0032975664 10.1111/j.1572-0241. 1999.01148.x (Pubitemid 29260449)
122. Akamatsu T., Watanabe N., Chiba T., Epstein-Barr virus-associated lymphoma developed shortly after immunosuppressive treatment for ulcerative colitis. Clinical Gastroenterology and Hepatology 2007 5 4 521 (Pubitemid 46575372)
123. Origgi L., Hu C., Bertetti E., Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome. Bollettino dell'Istituto Sieroterapico Milanese 1988 67 4 265 274
124. Yamaoka K., Miyasaka N., Yamamoto K., Possible involvement of Epstein-Barr virus in polyclonal b cell activation in sjogren's syndrome. Arthritis and Rheumatism 1988 31 8 1014 1021 2-s2.0-0023694348
125. Coyle P. V., Wyatt D., Connolly J. H., O'Brien C., Epstein-Barr virus infection and thyroid dysfunction. Lancet 1989 1 8643 899 2-s2.0-0024580820 (Pubitemid 19107898)
126. Pedersen R. K., Pedersen N. T., Primary non-hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996 28 1 25 32 2-s2.0-0030065545 (Pubitemid 26040138)
127. Alspaugh M. A., Henle G., Lennette E. T., Henle W., Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. Journal of Clinical Investigation 1981 67 4 1134 1140 2-s2.0-0019405436 (Pubitemid 11090554)
128. Balandraud N., Meynard J. B., Auger I., Sovran H., Mugnier B., Reviron D., Roudier J., Roudier C., Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis and Rheumatism 2003 48 5 1223 1228 2-s2.0-0038667529 10.1002/art.10933 (Pubitemid 36554521)
129. Niedobitek G., Lisner R., Swoboda B., Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis & Rheumatism 2000 43 1 151 154 (Pubitemid 30368224)
130. Scotet E., Peyrat M. A., Saulquin X., Retiere C., Couedel C., Davodeau F., Dulphy N., Toubert A., Bignon J. D., Lim A., Vie H., Hallet M. M., Liblau R., Weber M., Berthelot J. M., Houssaint E., Bonneville M., Frequent enrichment for cd8 t cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of t cell clonal expansions found in autoimmune inflammatory processes. European Journal of Immunology 1999 29 3 973 985 2-s2.0-0032985551 (Pubitemid 29119078)
131. Bogdanos D. P., Baum H., Grasso A., Okamoto M., Butler P., Ma Y., Rigopoulou E., Montalto P., Davies E. T., Burroughs A. K., Vergani D., Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. Journal of Hepatology 2004 40 1 31 39 2-s2.0-0346689993 10.1016/S0168-8278(03)00501-4 (Pubitemid 38064710)
132. Bogdanos D. P., Choudhuri K., Vergani D., Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001 21 4 225 232 2-s2.0-0034926765 10.1034/j.1600-0676.2001.021004225.x (Pubitemid 32677377)
133. Bogdanos D. P., Komorowski L., Disease-specific autoantibodies in primary biliary cirrhosis. Clinica Chimica Acta 2011 412 7-8 502 512 2-s2.0-79551490697 10.1016/j.cca.2010.12.019
134. Bogdanos D. P., Rigopoulou E. I., Self-mimicking autoimmune domains of hepatitis C virus core antigen. Vaccine 2006 24 37-39 6173 6174 2-s2.0-33747590986 10.1016/j.vaccine.2006.05.069 (Pubitemid 44262414)
135. Bogdanos D. P., Okamoto M., Ma Y., Williams R., Mieli-Vergani G., Vergani D., Virus/self double reactivity characterises the humoral immune response in autoimmune hepatitis-2. Journal of Hepatology 2000 32, article 45
136. Lang H. L. E., Jacobsen H., Ikemizu S., Andersson C., Harlos K., Madsen L., Hjorth P., Sondergaard L., Svejgaard A., Wucherpfennig K., Stuart D. I., Bell J. I., Jones E. Y., Fugger L., A functional and structural basis for tcr cross-reactivity in multiple sclerosis. Nature Immunology 2002 3 10 940 943 2-s2.0-0036793245 10.1038/ni835 (Pubitemid 35154007)
137. Lerner M. R., Andrews N. C., Miller G., Steitz J. A., Two small rnas encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 1981 78 2 805 809 2-s2.0-0019444924 (Pubitemid 11159514)
138. Sabbatini A., Bombardieri S., Migliorini P., Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of smd and Epstein-Barr virus-encoded nuclear antigen EBNA I. European Journal of Immunology 1993 23 5 1146 1152 2-s2.0-0027529432 (Pubitemid 23120179)
139. Wucherpfennig K. W., Strominger J. L., Molecular mimicry in t cell-mediated autoimmunity: viral peptides activate human t cell clones specific for myelin basic protein. Cell 1995 80 5 695 705 2-s2.0-0028926223
140. Massa M., Mazzoli F., Pignatti P., De Benedetti F., Passalia M., Viola S., Samodal R., La Cava A., Giannoni F., Ollier W., Martini A., Albani S., Proinflammatory responses to self hla epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis and Rheumatism 2002 46 10 2721 2729 2-s2.0-0036822292 10.1002/art.10564 (Pubitemid 36118937)
141. Bogdanos D. P., Lenzi M., Okamoto M., Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. International Journal of Immunopathology and Pharmacology 2004 17 1 83 92 (Pubitemid 39572192)
142. Manns M. P., Griffin K. J., Sullivan K. F., Johnson E. F., Lkm-1 autoantibodies recognize a short linear sequence in p450iid6, a cytochrome p-450 monooxygenase. Journal of Clinical Investigation 1991 88 4 1370 1378 2-s2.0-0025992973
143. Vergani D., Mieli-Vergani G., Immunology of Autoimmune hepatitis. Current Opinion in Gastroenterology 2001 17 6 562 567
144. Bogdanos D. P., Ma Y., Hadzic N., Portmann B., Mieli-Vergani G., Vergani D., P0295 virus-self crossreactivity inducing De Novo autoimmune hepatitis eight-years after liver transplantation. Journal of Pediatric Gastroenterology & Nutrition 2004 39 S169
145. Bogdanos D. P., Pares A., Rodes J., Vergani D., Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain. The American Journal of Gastroenterology 2004 99 4 763 764
146. Xie W., Snyder M., Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proceedings of the National Academy of Sciences of the United States of America 1995 92 5 1639 1643 2-s2.0-0028907328 10.1073/pnas.92.5.1639
147. Vento S., Garofano T., Di Perri G., Dolci L., Concia E., Bassetti D., Identification of hepatitis a virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991 337 8751 1183 1187 2-s2.0-0025845888 10.1016/0140-6736(91)92858-Y
148. Vento S., Cainelli F., Is there a role for viruses in triggering autoimmune hepatitis? Autoimmunity Reviews 2004 3 1 61 69 2-s2.0-1042302181 10.1016/S1568-9972(03)00053-3 (Pubitemid 38197972)
149. Ferri S., Longhi M. S., De Molo C., Lalanne C., Muratori P., Granito A., Hussain M. J., Ma Y., Lenzi M., Mieli-Vergani G., Bianchi F. B., Vergani D., Muratori L., A multifaceted imbalance of t cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010 52 3 999 1007 2-s2.0-77956643943 10.1002/hep.23792
150. Aoki C. A., Roifman C. M., Lian Z. X., Bowlus C. L., Norman G. L., Shoenfeld Y., Mackay I. R., Eric Gershwin M., Il-2 receptor alpha deficiency and features of primary biliary cirrhosis. Journal of Autoimmunity 2006 27 1 50 53 2-s2.0-33747763675 10.1016/j.jaut.2006.04.005 (Pubitemid 44279361)
151. Wakabayashi K., Lian Z. X., Moritoki Y., Lan R. Y., Tsuneyama K., Chuang Y. H., Yang G. X., Ridgway W., Ueno Y., Ansari A. A., Coppel R. L., Mackay I. R., Gershwin M. E., Il-2 receptor α (-/-) mice and the development of primary biliary cirrhosis. Hepatology 2006 44 5 1240 1249 2-s2.0-33751002069 10.1002/hep.21385 (Pubitemid 44748374)
152. Lan R. Y., Cheng C., Lian Z. X., Tsuneyama K., Yang G. X., Moritoki Y., Chuang Y. H., Nakamura T., Saito S., Shimoda S., Tanaka A., Bowlus C. L., Takano Y., Ansari A. A., Coppel R. L., Gershwin M. E., Liver-targeted and peripheral blood alterations of regulatory t cells in primary biliary cirrhosis. Hepatology 2006 43 4 729 737 2-s2.0-33646000803 10.1002/hep.21123
153. Tsuda M., Torgerson T. R., Selmi C., Gambineri E., Carneiro-Sampaio M., Mannurita S. C., Leung P. S. C., Norman G. L., Gershwin M. E., The spectrum of autoantibodies in ipex syndrome is broad and includes anti-mitochondrial autoantibodies. Journal of Autoimmunity 2010 35 3 265 268 2-s2.0-77957782111 10.1016/j.jaut.2010.06.017
154. Lucas K. G., Ungar D., Comito M., Groh B., Epstein barr virus induced lymphoma in a child with ipex syndrome. Pediatric Blood and Cancer 2008 50 5 1056 1057 2-s2.0-41849130326 10.1002/pbc.21341 (Pubitemid 351500188)
155. Pender M. P., CD8+ T cell deficiency, Epstein-Barr virus infection, vitamin D deficiency and steps to autoimmunity: a unifying hypothesis. Autoimmune Diseases 2012 2012 16 10.1155/2012/189096 189096